Cisplatin-resistant lung cancer A549 cells have a twofold higher expression of Anxa1 localized to both the cell surface and cytoplasm, and Anxa1 knockdown increases sensitivity to cisplatin treatment [38]. This evidence concerns the gene ANXA1 and lung cancer.